Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. Signal., 10 August 2010
Vol. 3, Issue 134, p. ra60
[DOI: 10.1126/scisignal.2001104]

RESEARCH ARTICLES

The PI3K Isoforms p110{alpha} and p110{delta} Are Essential for Pre–B Cell Receptor Signaling and B Cell Development

Faruk Ramadani1, Daniel J. Bolland2, Fabien Garcon1, Juliet L. Emery1, Bart Vanhaesebroeck3, Anne E. Corcoran2, and Klaus Okkenhaug1*

1 Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, UK.
2 Chromatin and Gene Expression, Babraham Institute, Cambridge CB22 3AT, UK.
3 Centre for Cell Signaling, Institute of Cancer, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Abstract: B cell development is controlled by a series of checkpoints that ensure that the immunoglobulin (Ig)–encoding genes produce a functional B cell receptor (BCR) and antibodies. As part of this process, recombination-activating gene (Rag) proteins regulate the in-frame assembly of the Ig-encoding genes. The BCR consists of Ig proteins in complex with the immunoreceptor tyrosine-based activation motif (ITAM)–containing Ig{alpha} and Igβ chains. Whereas the activation of the tyrosine kinases Src and Syk is essential for BCR signaling, the pathways that act downstream of these kinases are incompletely defined. Previous work has revealed a key role for the p110{delta} isoform of phosphatidylinositol 3-kinase (PI3K) in agonist-induced BCR signaling; however, early B cell development and mature B cell survival, which depend on agonist-independent or "tonic" BCR signaling, are not substantially affected by a deficiency in p110{delta}. Here, we show that p110{alpha}, but not p110β, compensated in the absence of p110{delta} to promote early B cell development in the bone marrow and B cell survival in the spleen. In the absence of both p110{alpha} and p110{delta} activities, pre-BCR signaling failed to suppress the production of Rag proteins and to promote developmental progression of B cell progenitors. Unlike p110{delta}, however, p110{alpha} did not contribute to agonist-induced BCR signaling. These studies indicate that either p110{alpha} or p110{delta} can mediate tonic signaling from the BCR, but only p110{delta} can contribute to antigen-dependent activation of B cells.

* To whom correspondence should be addressed. E-mail: klaus.okkenhaug{at}bbsrc.ac.uk

Citation: F. Ramadani, D. J. Bolland, F. Garcon, J. L. Emery, B. Vanhaesebroeck, A. E. Corcoran, K. Okkenhaug, The PI3K Isoforms p110{alpha} and p110{delta} Are Essential for Pre–B Cell Receptor Signaling and B Cell Development. Sci. Signal. 3, ra60 (2010).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
P110{alpha}-mediated constitutive PI3K signaling limits the efficacy of p110{delta}-selective inhibition in mantle cell lymphoma, particularly with multiple relapse.
S. Iyengar, A. Clear, C. Bodor, L. Maharaj, A. Lee, M. Calaminici, J. Matthews, S. Iqbal, R. Auer, J. Gribben, et al. (2013)
Blood 121, 2274-2284
   Abstract »    Full Text »    PDF »
Selective Inhibition of Phosphoinositide 3-Kinase p110{alpha} Preserves Lymphocyte Function.
L. So, S. S. Yea, J. S. Oak, M. Lu, A. Manmadhan, Q. H. Ke, M. R. Janes, L. V. Kessler, J. M. Kucharski, L.-S. Li, et al. (2013)
J. Biol. Chem. 288, 5718-5731
   Abstract »    Full Text »    PDF »
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.
A. Wiestner (2012)
Blood 120, 4684-4691
   Abstract »    Full Text »    PDF »
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.
A. Wiestner (2012)
Hematology 2012, 88-96
   Abstract »    Full Text »    PDF »
Subnuclear cyclin D3 compartments and the coordinated regulation of proliferation and immunoglobulin variable gene repression.
S. E. Powers, M. Mandal, S. Matsuda, A. V. Miletic, M. H. Cato, A. Tanaka, R. C. Rickert, S. Koyasu, and M. R. Clark (2012)
J. Exp. Med. 209, 2199-2213
   Abstract »    Full Text »    PDF »
Pten Loss in CD4 T Cells Enhances Their Helper Function but Does Not Lead to Autoimmunity or Lymphoma.
D. R. Soond, F. Garcon, D. T. Patton, J. Rolf, M. Turner, C. Scudamore, O. A. Garden, and K. Okkenhaug (2012)
J. Immunol. 188, 5935-5943
   Abstract »    Full Text »    PDF »
PI3K{delta} Inhibitors in Cancer: Rationale and Serendipity Merge in the Clinic.
D. A. Fruman and C. Rommel (2011)
Cancer Discovery 1, 562-572
   Abstract »    Full Text »    PDF »
Science Signaling Podcast: 4 January 2011.
M. B. Yaffe and A. M. VanHook (2011)
Science Signaling 4, pc1
   Abstract »    Full Text »
B Cell Receptor Signaling: Picky About PI3Ks.
J. J. Limon and D. A. Fruman (2010)
Science Signaling 3, pe25
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882